Certara, Inc. vs Solventum
Certara, Inc. (CERT) and Solventum (SOLV) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $1.61B
- Last close
- $10.55
- 12 months
- +31.4%
- Market value
- $14.3B
- Last close
- $84.50
- 12 months
- +6.3%
At a glance
- The biggest part of Solventum's revenue is Cost of product, 76% of the total in its last annual report.
- By market value, Solventum ($14.3B) is about 8.9 times Certara, Inc. ($1.6B).
- Over the last 12 months Certara, Inc.'s share price moved +31.4% and Solventum's +6.3%; against the S&P 500 that is +25.7 points and +0.6 points.
- In their last fiscal years Certara, Inc. kept -0.4% of revenue as net income and Solventum 18.7%.
- In the last 90 days insiders reported 0 open-market purchases at Certara, Inc. and 0 at Solventum; members of Congress disclosed 0 trades in Certara, Inc. and 0 in Solventum.
- Next results: Certara, Inc. Feb 24, 2027, Solventum Feb 24, 2027.
How each one makes money: Certara, Inc. revenue · Solventum revenue
Share prices on one chart
Certara, Inc. and Solventum, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Certara, Inc. CERTNASDAQ · Health Care Technology | Solventum SOLVNYSE · Health Care Technology | |
|---|---|---|
| Size and profitability | ||
| Market value | $1.61B | $14.3B |
| Revenue, last fiscal year | $419M | $8.32B |
| Net income, last fiscal year | −$1.59M | $1.56B |
| Net marginNet income as a share of revenue | -0.4% | 18.7% |
| Free cash flow | $94.6M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Solventum against
Common questions
How is Certara, Inc. different from Solventum?
Certara, Inc. (CERT) is in Health Care Technology on NASDAQ, with $419M of revenue in its last fiscal year and a net margin of -0.4%. Solventum (SOLV) is in Health Care Technology on NYSE, with $8.32B of revenue in its last fiscal year and a net margin of 18.7%. The biggest part of Solventum's revenue is Cost of product, 76% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Certara, Inc. and Solventum compare in size?
Solventum has the larger market value: Certara, Inc. $1.61B and Solventum $14.3B, at the last close.
Whose share price rose more over the last 12 months, CERT or SOLV?
Over the last 12 months Certara, Inc. moved +31.4% and Solventum +6.3%. Past price moves say nothing about the future.
Which has had more insider buying, Certara, Inc. or Solventum?
Since 2006, Certara, Inc. insiders reported 9 open-market purchases against 1 for Solventum. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CERT or SOLV?
In the last 12 months, members of Congress disclosed 0 trades in Certara, Inc. (CERT) and 3 in Solventum (SOLV).
When did insiders last buy CERT and SOLV?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Certara, Inc. pageSolventum pageRare insider trades this weekAll comparisons
https://oqro.io/compare/cert-vs-solv


